MedTrace Logo

Walnuts and Healthy Aging

NCT01634841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 708

Last updated 2021-06-24

No results posted yet for this study

Summary

This will be a systematic investigation of the role of walnuts in preventing or slowing age related cognitive decline and age related macular degeneration. 700 subjects will be recruited between 2 sites, Loma Linda University in California, USA and Hospital Clinic in Barcelona, Spain. Participants will be randomly assigned to either the walnut group or the control group for a 2 year intervention. Baseline and annual data will be collected and analyzed.

Conditions

  • Age Related Cognitive Decline
  • Age Related Macular Degeneration

Interventions

DIETARY_SUPPLEMENT

Walnuts

30 to 60g (1 to 2 oz) per day of walnuts

OTHER

habitual diet

Dietary information will be provided

Sponsors & Collaborators

  • University of Barcelona

    collaborator OTHER

  • California Walnut Commission

    collaborator OTHER

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Joan Sabate, MD, DrPH · Chair, Department of Nutrition

  • Emilio Ros, MD, PhD · Director Lipid Clinic, Endocrinology & Nutrition Service

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
63 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01634841 on ClinicalTrials.gov